|
|
![]() | ![]() | ![]() | ![]() |
This excerpt taken from the WBMD 10-Q filed May 11, 2009. Summary
of Stock-Based Compensation Expense
The following table summarizes the components and classification
of stock-based compensation expense:
As of March 31, 2009, approximately $470 and $72,895 of
unrecognized stock-based compensation expense related to
unvested awards (net of estimated forfeitures) is expected to be
recognized over a weighted-average period of approximately
3.0 years and 3.4 years related to the HLTH Plans and
the WebMD Plans, respectively.
Table of Contents
This Item 2 contains forward-looking statements with
respect to possible events, outcomes or results that are, and
are expected to continue to be, subject to risks, uncertainties
and contingencies, including those identified in this Item. See
Forward-Looking Statements on page 3.
This excerpt taken from the WBMD 10-Q filed May 12, 2008. Summary
of Stock-Based Compensation Expense
The following table summarizes the components and classification
of stock-based compensation expense:
As of March 31, 2008, approximately $404 and $35,842 of
unrecognized stock-based compensation expense related to
unvested awards (net of estimated forfeitures) is expected to be
recognized over a weighted-average period of approximately
0.69 years and 1.50 years related to the HLTH Plans
and the WebMD Plans, respectively.
This excerpt taken from the WBMD 10-Q filed May 10, 2007. Summary
of Stock-Based Compensation Expense
The following table summarizes the components and classification
of stock-based compensation expense:
No tax benefits were attributed to the stock-based compensation
expense because a valuation allowance was maintained for
substantially all net deferred tax assets. As of March 31,
2007, approximately $2,091 and $41,615 of unrecognized
stock-based compensation expense related to unvested awards (net
of estimated forfeitures) is expected to be recognized over a
weighted-average period of approximately 0.82 years and
1.87 years related to the Emdeon Plans and the WebMD Plans,
respectively.
| EXCERPTS ON THIS PAGE:
RELATED TOPICS for WBMD: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||